Development of liquid Bi target for continuous production of therapeutic radionuclide astatine-211, 1; Liq. Bi target project overview

Ishioka, Noriko*; Watanabe, Shigeki*; Kondo, Hiroo*; Takai, Toshihide ; Furukawa, Tomohiro

This paper reports the project overview of a liquid bismuth target development for the continuous and large-scale production of astatine-211 ( $^{211}$ At), which is a promising next-generation cancer medicine to be administered to the body.

Language	:	Japanese
Journal	:
Volume	:
Number	:
Pages	:
Publication Year/Month	:
Meeting title	:	日本原子力学会2019年秋の大会
Held date	:	2019/09
Location (city)	:	富山
Location (country)	:	日本
Patent information	:
PDF	:
Paper URL	:
DOI for research data	:
Keywords	:	ビスマス; 液体金属; イオンビーム; RI製造; 標的アイソトープ治療
Research Facility	:
Press Release	:
Article of JAEA R&D Review	:
Cooperating Institute	:	量子科学技術研究開発機構

Accesses	:	- Accesses
Web of Science® Times Cited Count	:	Times Cited Count： If you would like to get the latest times cited, please access the Web of Science®. http://www.webofknowledge.com/wos
InCites™	:
Altmetrics	:

Registration No. : BB20190606
JAEA Abstracts No. :
Paper Submission No. :

[CLARIVATE ANALYTICS], [WEB OF SCIENCE], [HIGHLY CITED PAPER & CUP LOGO] and [HOT PAPER & FIRE LOGO] are trademarks of Clarivate Analytics, and/or its affiliated company or companies, and used herein by permission and/or license.